Kura Oncology CEO Purchases $1.2 Million Worth of Shares
On August 24, 2026, Troy Edward Wilson, the President and CEO of Kura Oncology (NASDAQ: KURA), purchased approximately 100,000 shares for a total value of $1.2 million at an average price of $12.39 per share. This transaction increased his direct and indirect holdings to around 1.2 million shares in the company. The purchase occurred as the stock was trading near its 52-week high, with Kura Oncology maintaining a market capitalization of approximately $1.1 billion. Despite this insider activity, the company reported trailing twelve-month revenue of $77.2 million and a net loss of $296.8 million for the same period. The CEO's investment is notable as it reflects confidence in Kura Oncology’s future prospects amid ongoing clinical development efforts focused on targeted cancer therapies.
Tickers: $KURA
Topics: biotechnology healthcare stock_purchase